<DOC>
	<DOCNO>NCT01994707</DOCNO>
	<brief_summary>The investigator aim definitively show human myocardium remotely precondition . In writings experiment would prove remote precondition protocol effect high protection human myocardial cell , ischemia-reperfusion injury . 120 patient refer coronary artery bypass grafting ( CABG ) procedure use cardiopulmonary bypass plan include research . Patients randomize ( 1:1 ) one two group : remote precondition `` placebo '' intervention . On day surgery , induction anesthesia remote precondition elicit 3 cycle 5min inflation ( ischemia ) 5 min deflation ( reperfusion ) blood pressure cuff right arm . In control group blood pressure cuff go place upper limb precondition protocol carry . On cannulation CPB , right atrial appendage myocardial biopsy leave ventricular harvest . The investigator study : ( 1 ) resistance myocardium hypoxia/reperfusion injury vitro experiment , assess isolated right atrial pectinate muscle trabecula ( 2 ) induction apoptosis status mitochondrion myocardium period ischemia , reperfusion vitro ( 3 ) amount myocardial necrosis in-vivo induced period ischemia reperfusion CABG assess postoperative myocardial necrosis marker release ( 4 ) systolic function myocardium postoperative kidney function postoperative period evaluate creatinine clearance ; ( 5 ) induction apoptosis status mitochondrion myocardium period ischemia , reperfusion coronary artery bypass grafting , assess myocardial . There go ability define remote precondition influence occurrence apoptosis human myocardium vivo condition influence postoperative course patient undergoing cardiac surgery procedure . The investigator try study remote precondition modify induction apoptosis structure response injury . In case effect remote precondition measurable ex-vivo assessment , future attempt implement phenomenon clinical practice may futile continued effect confirm controlled experimental setting .</brief_summary>
	<brief_title>Remote Ischemic Preconditioning Human Myocardium</brief_title>
	<detailed_description>The investigator study : 1 . Resistance isolate right atrial pectinate muscle trabecula simulate hypoxia/reperfusion functional organ bath model 2 . Resistance isolate right atrial pectinate muscle trabecula induction apoptosis simulate hypoxia/reperfusion 3 . Resistance mitochondrion isolate right atrial pectinate muscle trabecula change induce simulated hypoxia/reperfusion Simultaneously ass : 1 . Amount myocardial necrosis vivo induced period ischemia reperfusion coronary artery bypass grafting ( CABG ) assess postoperative myocardial necrosis marker release profile 2 . Myocardial function vivo period ischemia reperfusion CABG assess hemodynamic measurement ( thermodilution method ) , oxygen supply/consumption inotropic support requirement 3 . Induction apoptosis status mitochondrion period ischemia , reperfusion CABG assess leave ventricular myocardial biopsy The investigator try correlate vitro vivo finding patient . Methodology The study conduct vivo ex-vivo . Patients refer CABG stable coronary artery disease recruit randomize ( 1:1 ) random digit generator one two group : remote precondition `` placebo '' intervention . Only patient least 3 coronary artery bypass graft use cardiopulmonary bypass ( CPB ) plan include . On day surgery , induction anesthesia skin incision remote precondition elicit . The `` placebo '' group pressure cuff place right arm inflation perform . To obtain blinding , inflation occur surgical drape , perform person every time , involved random sequence generation , remote precondition application , care patient , research related task . All consent patient preoperative echocardiography , electrocardiography blood test include fool blood count , creatinine , BUN , liver function test perform part routine preoperative care . Additionally troponin T CK-MB level assess . Furthermore patient perform electrocardiography 1st day operation . Anesthesia standardize consist midazolam 15mg orally 1h surgery , etomidate 0.2mg/kg , fentanyl 5g/kg pancuronium 0.1mg/kg iv anesthesia induction , propofol 0.5-1.0 mg/kg/h fentanyl 4g/kg/h infusion anesthesia maintenance . No anesthetic gas use . Full hemodynamic monitoring use Swan-Ganz catheter ( routine CABG patient ) . First hemodynamic measurement oxygen supply/consumption calculation perform preoperatively . Functional vitro assessment . On cannulation CPB , right atrial appendage , routinely remove discarded venous cannula placement harvest patient . The tissue transfer ice cold Krebs-Henseleit solution isolate organ laboratory department . One pectinate muscle trabecula harvest baseline assessment apoptosis mitochondrion ( see ) . Another single trabecula le 1mm diameter mount organ chamber - Schuler Organbath ( Hugo Sachs Elektronik , March-Hugstetten , Germany ( HSE ) ) contain Krebs-Henseleit solution . It oxygenate via glass frit carbogen ( 95 % oxygen , 5 % carbon dioxide ) maintain 37°C . The trabecula drive 1Hz 50ms square stimulus use platinum field electrodes potential 150 % threshold give preparation . The stimulator Type 215 ( HSE ) use . The contraction force measure F30 isometric force transducer Type 372 ( HSE ) . The signal enhance TAM A PlagSYS transducer amplifier module Type705 ( HSE ) record use PowerLab/4SP system Chart software ( AD Instruments ) . The trabecula gradually stretch 90 % optimal tension accord Frank-Starling relationship leave 30min stabilization washout . 60min ischemia simulate substitute oxygen carbogen argon ( 95 % argon , 5 % carbon dioxide ) replace Krebs-Henseleit solution one containing glucose pyruvate . On reoxygenation carbogen add tissue bath solution replace one use initially . The tissue wash several time leave 120min reoxygenation period washout every 15 min . This functional model hypoxia reoxygenation use laboratory [ 12-14 ] . Replacement oxygen argon result drop tissue bath oxygen partial pressure 475±52mmHg 51±1.8mmHg ( p &lt; 0.001 ) [ 37-39 ] . It accompany significant rapid decline isometric contraction force . During reoxygenation contraction force return initially next observe slow decline muscle inotropism interpret development reoxygenation injury . At end , use 10-4 M norepinephrine ( ( - ) -Arterenol Bitartrate ) test stunning . The contraction force record continuously . Contractility express percent initial contraction force give preparation . The investigator compare maximal recover contraction force , contraction force 30min 120min reoxygenation contraction force produce add 10-4M norepinephrine end reoxygenation . The investigator also look sign ischemic contracture development define increase rest tension trabecula . This increase , present , start shortly onset hypoxia continue steadily throughout whole hypoxia period . The investigator compare increase rest tension ( mN/mg tissue mass ) end hypoxia , time maximal contracture . All measurement , particular recovery function compare trabecula remotely precondition `` placebo '' patient . Two atrial trabecula appendage , one harvest baseline , another subject functional experiment ( 60 min hypoxia + 120 min reoxygenation ) study time : - apoptosis induction - Caspase 3 cleave Caspase 3 , PARP cleave PARP expression measure Western-Blot , - apoptosis induction - assessed TUNEL immunohistochemistry stain Caspase 3 , cleave Caspase 3 , PARP cleave PARP , - state mitochondrion ( electron microscopy ) As plan randomize 120 patient ( see ) material apoptosis mitochondrion study randomly take 60 patient ( 30:30 ) Western Blot , 40 patient ( 20:20 ) immunohistochemistry TUNEL , 20 patient ( 10:10 ) electron microscopy . Western Blot ( 2 trabecula , baseline hypoxia/reoxygenation , 30 remotely precondition 30 `` placebo '' patient ) . For Western Blot immunoassay trabecula place liquid nitrogen Immunohistochemistry ( 2 trabecula , baseline hypoxia/reoxygenation , 20 remotely precondition 20 `` placebo '' patient ) . Expression Caspase 3 , cleave Caspase 3 , PARP cleave PARP protein tissue section detect immunohistochemically . Trabeculae fix overnight 10 % neutral-buffered formalin ( phosphate buffer ) , subsequently pass grade alcohol solution , process three time xylene , finally embed paraffin block . The documentation immunohistochemical reaction perform SSC-DC58AP camera ( Sony ) couple Nikon Eclipse E400 optical microscope . TUNEL ( terminal deoxynucleotidyl transferase dUTP nick label ) ( 2 trabecula , baseline hypoxia/reoxygenation , 20 remotely precondition 20 `` placebo '' patient ) . Tissue section deparaffinized 2 change xylene 5 minute , hydrate 2 change 100 % ethanol 3 minute , 95 % ethanol 1 minute . The documentation immunohistochemical reaction perform SSC-DC58AP camera ( Sony ) couple Nikon Eclipse E400 optical microscope . Electron microscopy ( 2 trabecula , baseline hypoxia/reoxygenation , 10 remotely precondition 10 `` placebo '' patient ) . Trabeculae place cacodyl buffer 2 % glutaraldehyde . The mitochondrion micrographed JEOL-JEM 100CX transmission electron microscope ( JEOL Inc , Peabody , Mass ) magnification x16000 . The electron micrographs next saved mitochondrion size structure analyze use Image ProPlus software ( Media Scanalytics ) . The vivo trial The operation perform use CPB normothermia experience cardiac surgeon . Intermittent warm-blood ( 37°C ) antegrade cardioplegia ( miniplegia ) use myocardial protection . As patient require least 3 coronary bypass graft recruit , expect aortic crossclamp time last least 30 minute . After cross clamp removal proximal anastomosis perform use side biting clamp . The patient wean CPB , hemostasis secure chest closed chest tube . Just closing chest 16G needle-true cut biopsy leave ventricular myocardium obtain apex area . The investigator expect reperfusion time cross-clamp removal obtain biopsy last least 40 min . The exact ischemia ( cross-clamp ) time , reperfusion time ( obtain biopsy ) measure . The myocardial biopsy harvest assessed way atrial trabecule . The investigator randomly perform Western blot 60 ( 30:30 ) biopsy harvest liquid nitrogen , immunohistochemistry include TUNEL 40 ( 20:20 ) harvest 10 % neutral buffer formalin , electron microscopy 20 ( 10:10 ) harvest cacodyl buffer 2 % glutaraldehyde . The method assess Caspase3 , cleave Caspase 3 , PARP , cleave PARP , TUNEL mitochondrion described . After operation patient transfer ICU treat per routine . The primary endpoint clinical observation postoperative release cardiac troponin T. The investigator measure serum concentration cardiac Troponin T ( electrochemiluminescence `` ECLIA '' , Roche ) preoperatively next 72h cross-clamp removal . At time point level creatine kinase isoenzyme MB assess ( enzymatic assay , Roche ) . The area curve marker level time compare group . To assess myocardial function patient pulmonary artery catheter ( Swan Ganz catheter ) insert preoperatively . Full hemodynamic assessment ( thermodilution method ) well oxygen metabolism status base arterial mixed venous gas analysis perform preoperatively next 48h aortic cross-clamp removal . Apart measure cardiac index calculate leave right cardiac work index . The oxygen delivery index extraction ratio calculate . The lactate level also measure . The investigator also assess need inotropic support time point use call inotropic index . All patient postoperative electrocardiogram day 2 4 per postoperative care routine additionally 1st day operation . Similarly routine postoperative test perform part routine postoperative care perform , monitor use look difference postoperative course . This include echocardiography well creatinine ( eGFR ) .</detailed_description>
	<criteria>1 . Patients gender . 2 . Patients stable coronary artery disease refer surgical revascularization least 3 coronary artery bypass graft plan use cardiopulmonary bypass . 1 . Age 18 80 . 2 . Plan use radial artery graft . 3 . Plan perform concomitant cardiac procedure addition CABG . 4 . Diabetes mellitus . 5 . Troponin T level surgery excess 99th percentile upper reference limit . 6 . Acute coronary syndrome last 14 day surgery . 7 . Angina pectoris last 48 hour surgery . 8 . Significant peripheral vascular disease . 9 . Renal disease either creatinine level ≥ 2mg/dl estimate glomerular filtration rate &lt; 30ml/h/1.73m2 . 10 . Renal replacement therapy . 11 . Clinically relevant hepatic insufficiency bilirubin level least 1.5 time upper limit normal AlAT , AST level least 2 time upper limit normal . 12 . Advanced lung disease FEV1 &lt; 40 % predict value . 13 . Severe systolic dysfunction leave ventricle ( EF &lt; 35 % ) . 14 . Pregnancy . 15 . Psychiatric disease . 16 . Drug alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Remote ischemic preconditioning</keyword>
	<keyword>Coronary artery bypass graft surgery</keyword>
	<keyword>Troponin T</keyword>
	<keyword>Apoptosis</keyword>
	<keyword>Experimental</keyword>
	<keyword>Cardioprotection</keyword>
</DOC>